Glucocorticoid Therapy increases the cardiovascular Risk in RA Patients

被引：0
|
作者：
Di Lellis, Maddalena Angela
机构：
来源：
AKTUELLE RHEUMATOLOGIE | 2024年 / 49卷 / 04期
关键词：
D O I：
10.1055/a-2246-4107
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The risk of cardiovascular events (CVE) in RA patients is increased by the use of glucocorticoids. Whether there is a threshold dose and maximum duration of corticoid use beyond which the CVE rate is increased is controversial. So et al. investigated the time-varying effect of glucocorticoids and their dose on the risk of major adverse cardiovascular events (MACE) in patients with RA.
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Glucocorticoid receptor gene and risk of cardiovascular disease
    van den Akker, Erica L. T.
    Koper, Jan W.
    van Rossum, Elisabeth F. C.
    Dekker, Marieke J. H.
    Russcher, Henk
    de Jong, Frank H.
    Uitterlinden, Andre G.
    Hofman, Albert
    Pols, Huibert A.
    Witteman, Jacqueline C. M.
    Lamberts, Steven W. J.
    ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (01) : 33 - 39
  • [42] ORAL GLUCOCORTICOID USE IS ASSOCIATED WITH HYPERTENSION IN PATIENTS WITH RA
    Costello, Ruth E.
    Jani, Meghna
    Yimer, Belay B.
    Dixon, William G.
    RHEUMATOLOGY, 2020, 59
  • [43] Glucocorticoid Therapy and the Risk of Infection in Patients With Newly Diagnosed Autoimmune Disease
    Migita, Kiyoshi
    Sasaki, Yasuharu
    Ishizuka, Naoki
    Arai, Toru
    Kiyokawa, Tetsuyuki
    Suematsu, Eiichi
    Yoshimura, Mitsuhiro
    Kawabe, Yojiro
    Matsumura, Ryutaro
    Akagawa, Shinobu
    Mori, Shunsuke
    Shirai, Masahiro
    Watanabe, Yukio
    Minami, Naoya
    Soga, Takayoshi
    Owan, Isoko
    Ohshima, Shiro
    Yoshizawa, Shigeru
    Matsui, Toshihiro
    Tohma, Shigeto
    Bito, Seiji
    MEDICINE, 2013, 92 (05) : 285 - 293
  • [44] Disordered mineral metabolism increases the risk of cardiovascular morbidity in dialysis patients
    Noordzij, M.
    Korevaar, J. C.
    Bos, W. J.
    Boeschoten, E. W.
    Dekker, F. W.
    Bossuyt, P. M.
    Krediet, R. T.
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2006, 21 : 94 - 94
  • [45] Fatty Liver Additionally Increases Cardiovascular Risk in Diabetic Patients with Albuminuria
    Ljubic, Spomenka
    Tomic, Martina
    Jazbec, Anamarija
    Milotic, Dubravka Majic
    Piljac, Ante
    Lovrencic, Marijana Vucic
    DIABETES, 2014, 63 : A566 - A566
  • [46] Link between RA and cardiovascular disease risk
    Nature Reviews Rheumatology, 2015, 11 (7) : 382 - 382
  • [47] ADDRESSING CARDIOVASCULAR RISK IN TREATMENT RESISTANT RA
    Baxter, D.
    Ricketts, H. C.
    McCarey, D. W.
    McInnes, I. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 853 - 853
  • [48] TNF inhibitors and cardiovascular risk management in RA
    Janet E. Pope
    Nature Reviews Rheumatology, 2016, 12 : 317 - 318
  • [49] RA-lowering cardiovascular risk with statins
    Lee, Justin M. S.
    Choudhury, Robin P.
    NATURE REVIEWS RHEUMATOLOGY, 2010, 6 (03) : 123 - 124
  • [50] In utero glucocorticoid exposure increases risk of neurodevelopemental disorders
    Reactions Weekly, 2025, 2042 (1) : 11 - 11
12345